Benzodiazepine and opioid co-usage in the US population, 1999–2014: an exploratory analysis
- 17 January 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 42 (4)
Abstract
The study objectives were to explore trends in prevalence of co-use of benzodiazepine receptor modulators and opioids, and non-selective and selective (i.e., Z-drugs) benzodiazepine receptor modulators, in the United States, as well as risk factors for these drug utilization patterns. This was a multi-year, cross-sectional, population-level study, using United States health survey data. Data from eight National Health and Nutrition Examination Survey (NHANES) cycles were analyzed, from 1999–2000 until 2013–2014, with each survey cycle containing information on ~10,000 individuals. The main measure was prevalent prescription drug use within 30 days preceding survey administration. Drug usage was objectively confirmed for a large majority of participants though direct inspection of prescription bottles. The estimated prevalence of concurrent benzodiazepine receptor modulator and opioid use in the United States was 0.39% in 1999–2000 and 1.36% in 2013–2014, reflecting absolute and relative changes of +0.97% and +249%. The estimated prevalence of non-selective and selective benzodiazepine receptor modulator co-use steadily rose in the United States from 0.05% in 1999–2000 to 0.47% in 2013–2014, reflecting absolute and relative increases of +0.42% and +840%. Independent risk factors for these two forms of psychoactive medication polypharmacy were identified. In this exploratory analysis, concurrent use of benzodiazepine receptor modulators and opioids, and non-selective and selective benzodiazepine receptor modulators, was found to have progressively risen in the United States. The progressive increases in these two forms of psychoactive medication polypharmacy is concerning, given that these drug use patterns are associated with increased risk for serious adverse outcomes.Keywords
This publication has 61 references indexed in Scilit:
- Sedative Medication Use: Prevalence, Risk Factors, and Associations with Body Mass Index Using Population-Level DataSLEEP, 2011
- Lifetime body mass index, other anthropometric measures of obesity and risk of knee or hip osteoarthritis in the GOAL case-control studyOsteoarthritis and Cartilage, 2011
- Age and Gender Trends in Long-Term Opioid Analgesic Use for Noncancer PainAmerican Journal of Public Health, 2010
- Sleep problems in general practice: a national survey of assessment and treatment routines of general practitioners in NorwayJournal of Sleep Research, 2010
- A Systematic Evaluation of Factors Associated With Nocturia—The Population-based FINNO StudyAmerican Journal of Epidemiology, 2009
- A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndromeSleep Medicine, 2007
- GABA-based therapeutic approaches: GABAA receptor subtype functionsCurrent Opinion in Pharmacology, 2006
- Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefitsBMJ, 2005
- Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS)Sleep Medicine, 2004
- Zolpidem-polysomnographic study of the effect of a new hypnotic drug in sleep apnea syndromePharmacology Biochemistry and Behavior, 1988